Loading
Latest filing published 03 Nov 2023 for Tryp Therapeutics Inc., €147k.
No signal scores available.
All filings by James Patrick Gilligan on record concern Tryp Therapeutics Inc. Between 22 April 2022 and 30 October 2023, the trades on record add up to 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 3 November 2023 came the latest disclosure, an option exercise for €147k in Tryp Therapeutics Inc. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations